Papers to Watch

X. Zhang et al., "An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor," Cell, 125:1137-49, June 16, 2006.This structural/biochemical study provides compelling evidence that the epidermal growth factor (EGF) receptor kinase domain is activated through formation of an asymmetric dimer, in which the C-lobe of one kinase domain impinges on the N-lobe of the other kinase domain, activating the latter.Stevan Hubbard New York Unive

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

X. Zhang et al., "An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor," Cell, 125:1137-49, June 16, 2006.

This structural/biochemical study provides compelling evidence that the epidermal growth factor (EGF) receptor kinase domain is activated through formation of an asymmetric dimer, in which the C-lobe of one kinase domain impinges on the N-lobe of the other kinase domain, activating the latter.

Stevan Hubbard
New York University School of Medicine, USA

J. Wang et al., "Platensimycin is a selective FabF inhibitor with potent antibiotic properties," Nature, 441:358-61, May 18, 2006.

This paper reports the discovery and characterization of a new compound, platensimycin, that seems to have broad-spectrum, Gram-positive antibiotic activity by binding to the catalytic apparatus of a known antibacterial target FabF.

Xiayang Qiu
Pfizer Inc., USA

S. Wang et al., "Venular basement membranes contain specific matrix protein low expression regions that act as exit points ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies